BMJ:女性第-作者在高影响力医学期刊的论文发表情况研究

2016-03-07 MedSci MedSci原创

目的:为了评估1994-2014年女性为原始研究的第一作者发表在高影响力综合医学期刊上的数量变化,并调查不同期刊间的差距。

目的:为了评估1994-2014年女性为原始研究的第一作者发表在高影响力综合医学期刊上的数量变化,并调查不同期刊间的差距。


这是一个观察性研究。研究样本为1994年到2014年每隔一个月出版在《内科学年鉴》(Annals of Internal Medicine),《内科学档案》(Archives of Internal Medicine),《英国医学杂志》(BMJ)、《美国医学会杂志》(JAMA)、《新英格兰杂志》(NEJM)上的原始研究。主要暴露因素为时间和出版的期刊。

主要结局测量:女性为第一作者的数量和调整时间和期刊后的数量,使用多变量逻辑回归模型计算作者数量,研究类型和专业/主题,研究进行的地点,出版期刊和时间,研究类型,地点之间的相互关系。使用模型估算的数据计算6个期刊调整的风险比,使用95%可信区间和P值来描述相关性。

结局:在3860篇文献中,考虑第一作者性别的文章有3758篇,其中1273(34%)篇第一作者为女性。调整后,女性第一作者从1994年的27%显著增加到2014年的37%(P < 0.001)。NEJM似乎有不同的模式,女性第一作者数量减少;BMJ最近几年数量似乎也下降了,但BMJ拥有最高的女性第一作者比例。比较所有6个期刊,研究期间NEJM上的女性第一作者明显要少 (调整后的优势比为0.68,95%CI 0.53到0.89),女性第一作者更有可能出现在BMJ上 (1.30,1.01,1.66)。

结论:2014年女性为原始研究的第一作者发表在高影响力综合医学期刊上的数量较20年前显著增高,在近几年趋于平衡,并在几个期刊中有下降趋势。这些结果,以及在不同期刊间的重要差异,表明了女性为研究代表人发表高影响力期刊的的名额不够, 这仍是一个重要的问题。需要对潜在的原因进行调查,帮助确定经验和策略来提高女性在决定未来的临床策略和实践标准上的贡献和影响力。

原始出处:

Giovanni Filardo, Briget da Graca, et al,Trends and comparison of female first authorship in high impact medical journals: observational study (1994-2014),BMJ 2016; 352 doi: http://dx.doi.org/10.1136/bmj.i847 (Published 02 March 2016)


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1847931, encodeId=3c03184e9316c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Nov 30 21:29:00 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947083, encodeId=4974194e0832d, content=<a href='/topic/show?id=2ac250319fe' target=_blank style='color:#2F92EE;'>#影响力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50319, encryptionId=2ac250319fe, topicName=影响力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Thu Dec 15 20:29:00 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=68404, encodeId=48de68404c6, content=正常, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Mar 09 16:49:00 CST 2016, time=2016-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466470, encodeId=52a014664e0ba, content=<a href='/topic/show?id=04469139114' target=_blank style='color:#2F92EE;'>#论文发表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91391, encryptionId=04469139114, topicName=论文发表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37e96815787, createdName=yeaweam, createdTime=Wed Mar 09 07:29:00 CST 2016, time=2016-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513903, encodeId=2b4615139035d, content=<a href='/topic/show?id=45ca34140ec' target=_blank style='color:#2F92EE;'>#医学期刊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34140, encryptionId=45ca34140ec, topicName=医学期刊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a210597497, createdName=1249884fm90暂无昵称, createdTime=Wed Mar 09 07:29:00 CST 2016, time=2016-03-09, status=1, ipAttribution=)]
    2016-11-30 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1847931, encodeId=3c03184e9316c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Nov 30 21:29:00 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947083, encodeId=4974194e0832d, content=<a href='/topic/show?id=2ac250319fe' target=_blank style='color:#2F92EE;'>#影响力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50319, encryptionId=2ac250319fe, topicName=影响力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Thu Dec 15 20:29:00 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=68404, encodeId=48de68404c6, content=正常, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Mar 09 16:49:00 CST 2016, time=2016-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466470, encodeId=52a014664e0ba, content=<a href='/topic/show?id=04469139114' target=_blank style='color:#2F92EE;'>#论文发表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91391, encryptionId=04469139114, topicName=论文发表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37e96815787, createdName=yeaweam, createdTime=Wed Mar 09 07:29:00 CST 2016, time=2016-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513903, encodeId=2b4615139035d, content=<a href='/topic/show?id=45ca34140ec' target=_blank style='color:#2F92EE;'>#医学期刊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34140, encryptionId=45ca34140ec, topicName=医学期刊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a210597497, createdName=1249884fm90暂无昵称, createdTime=Wed Mar 09 07:29:00 CST 2016, time=2016-03-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1847931, encodeId=3c03184e9316c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Nov 30 21:29:00 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947083, encodeId=4974194e0832d, content=<a href='/topic/show?id=2ac250319fe' target=_blank style='color:#2F92EE;'>#影响力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50319, encryptionId=2ac250319fe, topicName=影响力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Thu Dec 15 20:29:00 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=68404, encodeId=48de68404c6, content=正常, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Mar 09 16:49:00 CST 2016, time=2016-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466470, encodeId=52a014664e0ba, content=<a href='/topic/show?id=04469139114' target=_blank style='color:#2F92EE;'>#论文发表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91391, encryptionId=04469139114, topicName=论文发表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37e96815787, createdName=yeaweam, createdTime=Wed Mar 09 07:29:00 CST 2016, time=2016-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513903, encodeId=2b4615139035d, content=<a href='/topic/show?id=45ca34140ec' target=_blank style='color:#2F92EE;'>#医学期刊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34140, encryptionId=45ca34140ec, topicName=医学期刊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a210597497, createdName=1249884fm90暂无昵称, createdTime=Wed Mar 09 07:29:00 CST 2016, time=2016-03-09, status=1, ipAttribution=)]
    2016-03-09 wei834766788

    正常

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1847931, encodeId=3c03184e9316c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Nov 30 21:29:00 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947083, encodeId=4974194e0832d, content=<a href='/topic/show?id=2ac250319fe' target=_blank style='color:#2F92EE;'>#影响力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50319, encryptionId=2ac250319fe, topicName=影响力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Thu Dec 15 20:29:00 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=68404, encodeId=48de68404c6, content=正常, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Mar 09 16:49:00 CST 2016, time=2016-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466470, encodeId=52a014664e0ba, content=<a href='/topic/show?id=04469139114' target=_blank style='color:#2F92EE;'>#论文发表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91391, encryptionId=04469139114, topicName=论文发表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37e96815787, createdName=yeaweam, createdTime=Wed Mar 09 07:29:00 CST 2016, time=2016-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513903, encodeId=2b4615139035d, content=<a href='/topic/show?id=45ca34140ec' target=_blank style='color:#2F92EE;'>#医学期刊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34140, encryptionId=45ca34140ec, topicName=医学期刊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a210597497, createdName=1249884fm90暂无昵称, createdTime=Wed Mar 09 07:29:00 CST 2016, time=2016-03-09, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1847931, encodeId=3c03184e9316c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Nov 30 21:29:00 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947083, encodeId=4974194e0832d, content=<a href='/topic/show?id=2ac250319fe' target=_blank style='color:#2F92EE;'>#影响力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50319, encryptionId=2ac250319fe, topicName=影响力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Thu Dec 15 20:29:00 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=68404, encodeId=48de68404c6, content=正常, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Mar 09 16:49:00 CST 2016, time=2016-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466470, encodeId=52a014664e0ba, content=<a href='/topic/show?id=04469139114' target=_blank style='color:#2F92EE;'>#论文发表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91391, encryptionId=04469139114, topicName=论文发表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37e96815787, createdName=yeaweam, createdTime=Wed Mar 09 07:29:00 CST 2016, time=2016-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513903, encodeId=2b4615139035d, content=<a href='/topic/show?id=45ca34140ec' target=_blank style='color:#2F92EE;'>#医学期刊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34140, encryptionId=45ca34140ec, topicName=医学期刊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a210597497, createdName=1249884fm90暂无昵称, createdTime=Wed Mar 09 07:29:00 CST 2016, time=2016-03-09, status=1, ipAttribution=)]

相关资讯

Obstet Gynecol:各临床科室女性领导人比例

目标:为了比较妇产科专业与其它临床科室女性领导人的比例。 方法:这是一个横断面观察性研究。比较不同部门领导人(主任、副主任、部门负责人)和住院医师项目负责人的性别。数据来源网站上950个学术部门的麻醉科,诊断放射科、普通外科,内科,神经科、妇产科、病理科、儿科、精神病学科。妇产科、病理科、儿科、精神病学科。用2013年各专业领导人为女性的比例除以1990年的比例算出比值比。计算95%可信区间

女性冠心病的十个“颠覆性认识”

心血管病是当今威胁女性生命和健康的主要疾病。中国的女性死因排序中,因心脏病死亡已超过了脑卒中和肿瘤,成为首位死亡原因。发达国家的男性冠心病患者的病死率已呈下降趋势。   但多年以来,女性的心血管病的研究和预防工作一直受到相对的忽视,女性的猝死发生率有逐渐升高的趋势。根据美国的资料,女性的猝死率从1989年的38%升至1999年的47%,女性在到达医院前猝死者多于男性(52%比42%)

Eur Respir J:女性患COPD的风险是男性的两倍!

来自瑞典隆德大学的研究人员通过一种新的诊断方法显示,女性患慢性阻塞性肺疾病的风险是男性的两倍。这意味着,“女性”可能是这种级别的一个独立的危险因素。隆德大学的研究员Johannes Luoto对有2300名年龄在65-100岁的参与者进行了研究。Johannes Luoto说:“我们发现女性患COPD的风险明显比男性高,将吸烟、年龄等危险因素纳入研究时,女性患COPD风险仍旧比男性高。”在这之前C

BMJ:女性足够的睡眠或许可以预防糖尿病

研究者对133 353名不伴糖尿病、心血管疾病和癌症的女性进行了数据分析,参与者来自两个队列:NHS 30-55岁,NHSⅡ 25-42岁。纳入研究时,NHS和NHSⅡ队列中分别有5.9%和4.8%的女性伴有睡眠困难(所有时间或大部分时间难以入睡或难以保持睡眠)。在随后的10年随访里,有6407名女性患上2型糖尿病。校正基线生活方式等因素后,研究者发现,睡眠困难的女性比正常女性,糖尿病风险高出45

BMJ:房颤是否是女性心血管疾病和死亡的较强风险因素?

该研究的目的是确定女性与男性相比,房颤是否是心血管疾病和死亡的较强的风险因素。原始出处:Connor A Emdin,Christopher X Wong,Allan J Hsiao,et al.Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men,BMJ

Circ J:女性是房颤相关的心源性卒中的危险因素

目的:CHA2DS2-VASc评分的大小不仅与中风的发病率有关而且与长期预后相关。AF-相关心源性卒中患者性别和初始卒中严重程度相关性尚未研究。本研究旨在探讨多中心注册研究中,心源性卒中患者初始卒中严重程度的危险因素。方法和结果  :在2001年1月到2013年7月间,研究者从日本标准脑卒中登记中心选择了12701例房颤相关的心源性卒中患者(年龄77±10岁;女性为5653)。应用多变量线性回归确